Novel therapeutic targets in bowel disease

Details for Australian Patent Application No. 2008312464 (hide)

Owner Salix Pharmaceuticals, Ltd. Govt. of the U.S.A., as represented by the Secretary Department of Health and Human Services

Inventors Johnson, Lorin; Ma, Xiaochao; Gonzalez, Frank J.

Agent Pizzeys

Pub. Number AU-A-2008312464

PCT Pub. Number WO2009/052255

Priority 60/999,234 17.10.07 US

Filing date 16 October 2008

Wipo publication date 23 April 2009

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

6 May 2010 PCT application entered the National Phase

  PCT publication WO2009/052255 Priority application(s): WO2009/052255

1 November 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008312465-Bowel purgative and uses thereof

2008312457-Cysteine engineered anti-TENB2 antibodies and antibody drug conjugates